EUVIMEDEUVIMED entdecken
Crossref

Gut–Pancreas Interactions and Microbiome-Based Biomarkers in the Early Prediction of Insulin Resistance

José Enrique González Araujo, Guadalupe Ximena Morales Pineda, Andres Felipe Quimbayo Cifuentes, Mayra Nayeli Estrada Garcia, Cristóbal Washington Franco Lucas, Raphaela Ballon Chehade, Maribel Villaseñor Landeros, Angel Isaias Pandashina Masabanda

International Science Journal · 2025

DOI: 10.64784/075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Science Journal, 2025. Verfasst von José Enrique González Araujo und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin resistance represents a critical stage in the development of type 2 diabetes mellitus (T2DM), frequently preceding clinical diagnosis by several years. Increasing evidence indicates that the gut–pancreas axis plays a central role in metabolic regulation through complex interactions between intestinal microbiota, microbial metabolites, inflammatory signaling, and pancreatic endocrine function. This review synthesizes current scientific evidence on the contribution of the gut–pancreas axis to insulin resistance, with particular emphasis on emerging microbiome-related biomarkers with potential predictive value for T2DM. A structured narrative review of peer-reviewed international literature was conducted, integrating experimental, observational, metagenomic, and interventional studies addressing gut microbiota composition, functional metabolic outputs, inflammatory pathways, and biomarker development. The findings indicate that functional microbial products, especially short-chain fatty acids, along with metabolic inflammation and endotoxemia-related mechanisms, are consistently associated with impaired insulin sensitivity. Metagenomic signatures and barrier-related interactions further support a systems-level role of the gut microbiome in metabolic dysregulation, while dietary and microbiota-based interventions demonstrate the modifiability of these pathways. Collectively, the evidence supports the gut–pancreas axis as a biologically coherent and clinically relevant framework for early risk stratification of insulin resistance. Integrative biomarker models combining microbial, inflammatory, and conventional metabolic indicators may enhance early prediction and inform preventive strategies across diverse populations.

Zitieren

APA

Araujo, J. E. G., Pineda, G. X. M., Cifuentes, A. F. Q., Garcia, M. N. E., Lucas, C. W. F., Chehade, R. B., Landeros, M. V., & Masabanda, A. I. P. (2025). Gut–Pancreas Interactions and Microbiome-Based Biomarkers in the Early Prediction of Insulin Resistance. International Science Journal. https://doi.org/10.64784/075

Vancouver

Araujo JEG, Pineda GXM, Cifuentes AFQ, Garcia MNE, Lucas CWF, Chehade RB, et al. Gut–Pancreas Interactions and Microbiome-Based Biomarkers in the Early Prediction of Insulin Resistance. International Science Journal. 2025. doi:10.64784/075

BibTeX
@article{Araujo2025,
  author = {Araujo, José Enrique González and Pineda, Guadalupe Ximena Morales and Cifuentes, Andres Felipe Quimbayo and Garcia, Mayra Nayeli Estrada and Lucas, Cristóbal Washington Franco and Chehade, Raphaela Ballon and Landeros, Maribel Villaseñor and Masabanda, Angel Isaias Pandashina},
  title = {Gut–Pancreas Interactions and Microbiome-Based Biomarkers in the Early Prediction of Insulin Resistance},
  journal = {International Science Journal},
  year = {2025},
  doi = {10.64784/075}
}
Kostenlos starten →